I’m going to be a Cardiologist! 🫀 Beyond thrilled to continue my training here at @InovaHealth. Grateful for my mentors & colleagues, friends, and loved ones who have supported me through this journey! @InovaCVfellows @ISHVnews @ShashankSinhaMD @JamieLWKennedy @GarimaVSharmaMD

Appreciate the opportunity to present these cases to the panel at #CritCareCards25! @CardioNerds @nyulangone 🙏🫀 Amazing conference with great learning and faculty!

Nice work! Congratulations

Excited to be in NYC for @nyulangone #CritCareCards25! 🫀🔥 Presenting 2 complex clinical cases. Use of ECPELLA in SCAI D/E as a bridge to native myocardial recovery selected as a top 10 finalist for @CardioNerds poster session 💜🤓 @InovaCVfellows @ISHVnews @ShashankSinhaMD

Nearly 900K echo measurements. 155K studies. A new open-source #AI nails automated echo parameters with precision ⚡ Meet EchoNet-Measurements: https://t.co/v06Z7YbJJ3 #JACC #ArtificialIntelligence #cvEcho #EPeeps @David_Ouyang

New #JACCINT analysis 📖 from #DanGerShock trial shows in #STEMI with cardiogenic shock and multivessel disease 🫀, immediate multivessel #PCI 💉 was linked to lower mortality ⬇️ vs culprit-only PCI. A potential lifesaving strategy 💡✨

Congratulations to Jacob and the Danger Shock team, at #ESC2025 they shared long terms outcomes from the trial, demonstrating persistent benefits of Impella in AMI-CS out to 10 years of follow up.

In #JACCHF Position Statement, @AdityaMehtaMD @PalakShahMD address diagnostic and therapeutic approaches for AMR in Heart Transplantation, and discuss unresolved questions and issues @coconnormd @JACCJournals https://t.co/J5U8OpvHZg

Beta-Blockers after Myocardial Infarction in Patients without Heart Failure: @NEJM @ESCCongress 🥸 Is evidence still in favor of beta blockers post AMI? #ESCCongress2025 😱Summary 👇👇👇

Delighted to share our paper in @Jaccjournals #JACCAdvances on CVH screening after #preeclampsia Cardiovascular Screening Rates With Establishment of Postpartum Cardiovascular Care Pathway for Hypertensive Disorders of Pregnancy | JACC: Advances https://t.co/7yIu115Cuy

Multidisciplinary team-based approach to CS, early SCAI & SHARC classification, rapid triage & escalation of care leads to myocardial recovery, illustrated by @ilanvavilinmd @ShashankSinhaMD et al in #JACCCaseReports @agtruesdell @AndrewNguyen_DO @vbluml @iyadisseh

Role of ECPELLA (VA-ECMO & Impella) as bridge to myocardial recovery in patient with SCAI stage D biventricular CS, described by @AndrewNguyen_DO @ShashankSinhaMD, et al in #JACCCaseReports @behnam_tehrani @ilanvavilinmd @agtruesdell @cmrosner https://t.co/bhNFjuIPT7

@ISHVnews @InovaCVfellows @ShashankSinhaMD @ilanvavilinmd @agtruesdell @behnam_tehrani @cmrosner @coconnormd @JamieLWKennedy @vbluml @iyadisseh

🔥 Hot off the press, I’m thrilled to share our remarkable patient success story! Part of the special issue for @JACCJournals Case Reports🚨 ECPELLA as a Bridge to Unexpected Myocardial Recovery in a Patient in Refractory Cardiogenic Shock 🫀 🔗⬇️ https://t.co/oyHWMj3A3x

Excited to share our patient success story. From Struggle to Triumph: A Journey Through SCAI Stages to Myocardial Recovery | JACC: Case Reports

Welcome to our August 13 special issue of #JACCCaseReports @JACCJournals on PATIENT SUCCESS STORIES! https://t.co/4acX849mgX Full PDF here: https://t.co/BNStxVnw0q @MinnowWalsh @DeeDeeWangMD @hmkyale @Justine_Turco Editor’s Page Celebrating Clinical Success Stories: Special

Happy hour, happy hearts! At @ISHVnews , @InovaCVfellows train together, grow together, and celebrate together 🫀💙 @iyadisseh @coconnormd @GarimaVSharmaMD @JamieLWKennedy

Cardiovascular Disease Fellowship Program @ISHVnews Honored to train the next leaders in the field · World Class Faculty · Dedicated Mentoring · Complex Patient Care · Outstanding Research Opportunities · Commitment to Innovation and Excellence https://t.co/BvZZmKG3WP

Please read our latest expert analysis for FAVOR III Europe clinical trial lead by superstar @ISHVnews resident @AndrewNguyen_DO . @ilanvavilinmd @InovaCVfellows @coconnormd @mw_sherwood @behnam_tehrani @ShashankSinhaMD @GarimaVSharmaMD @ACCinTouch @ACCMaryland @ACCVirginia

FAVOR III Europe was a multicenter, randomized, open-label, noninferiority trial to compare clinical outcomes of QFR-guided & FFR-guided #revascularization in patients with intermediate coronary stenosis at 12 months. Learn more: https://t.co/sJywTP4HZU #CardioX

Excited to share our expert analysis of the FAVOR-III Europe trial published in @ACCinTouch. Thank you @BakhshiHooman and @ilanvavilinmd for the opportunity! @ISHVnews @InovaCVfellows @InovaHealth